Mereo BioPharma Group PLC ADR (MREO) — Cash Flow Quality Index

Latest as of December 2021: -24.07x

Mereo BioPharma Group PLC ADR (MREO) has a Cash Flow Quality Index of -24.07x as of December 2021. Operating cash flow of $-20.89 Million is below net income of $867.99K, suggesting accrual-heavy earnings not yet converted to cash. Also explore total assets of Mereo BioPharma Group PLC ADR for the complete picture of this company's asset base.

Cash Flow Quality Index

-24.07x
Operating CF / Net Income

Operating Cash Flow

$-20.89 Million
USD

Net Income

$867.99K
USD

Data as of

Dec 2021
Most recent filing

Mereo BioPharma Group PLC ADR Cash Flow Quality Index (2021–2021)

Historical Cash Flow Quality Index for Mereo BioPharma Group PLC ADR across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Mereo BioPharma Group PLC ADR's equity to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Mereo BioPharma Group PLC ADR (2021–2021)

Year-by-year earnings quality comparison for Mereo BioPharma Group PLC ADR. For live market cap and the full company financial profile, see Mereo BioPharma Group PLC ADR market cap and net worth.

Year Quality Index Operating CF (USD) Net Income YoY Change
2021 -0.37x $-7.07 Million $19.22 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.